We believe in making a difference. And our heritage proves that passion for improving patient outcome, through leading technology and integrated medtech solutions, adds value to both healthcare and investors.
- Getinge B (STO)
- 16 May 2022 16:22
- 28.70 USD (-0.82%)
Are you looking for
Reports & presentations
Get access to the latest interim and annual reports as well as presentations or find the right one from the archive.
Information about the major shareholders, share price, dividend and total return as well as sell side analysts.
In the financial calendar you get information about upcoming events, such as coming reports.
Get access to the latest press releases and sign up for a subscription.
Getinge's financial risk management is centralized to capitalize on economies of scale, synergy effects and to minimize operational risks.
Capital Markets Day 2021
Getinge arranged a virtual Capital Markets Day on November 22, 2021.
Getinge applies a silent period of 30 days before quarterly reports.
Head of Investor Relations
Phone: +46 10 335 0043
Annual Report 2021
The Annual Report 2021 was published on March 30, 2022.
Order a printed copy of the report or read the report below.
Getinge Financing Framework for Social Bonds
Getinge has established a Framework to enable issuance of Social Bonds. Getinge has engaged Sustainalytics to provide an independent Second Party Opinion on the Social Financing Framework.
Rights Issue 2017
On June 14, 2017, Getinge announced the intention to launch a rights issue to strengthen the group’s balance sheet and provide the group an improved financial position. Due to legal restrictions, the information on this part of Getinge’s website is not accessible to certain persons.
Getinge is committed to the principles of corporate governance, all in order to promote business competitiveness as well as investor confidence.
We contribute to a sustainable future by acting socially responsible and reducing the environmental impact from our operations.
Getinge provides products and services for operating rooms, intensive-care units, hospital wards, sterilization departments and life science companies and institutions.